Hoon DS - Search Results

1

Quantification of circulating DNA in the plasma and serum of cancer patients.

Taback B, O'Day SJ, Hoon DS. Taback B, et al. Among authors: hoon ds. Ann N Y Acad Sci. 2004 Jun;1022:17-24. doi: 10.1196/annals.1318.004. Ann N Y Acad Sci. 2004. PMID: 15251934

2

Polyvalent melanoma vaccine improves survival of patients with metastatic melanoma.

Morton DL, Hoon DS, Nizze JA, Foshag LJ, Famatiga E, Wanek LA, Chang C, Irie RF, Gupta RK, Elashoff R. Morton DL, et al. Among authors: hoon ds. Ann N Y Acad Sci. 1993 Aug 12;690:120-34. doi: 10.1111/j.1749-6632.1993.tb44002.x. Ann N Y Acad Sci. 1993. PMID: 8368731 Clinical Trial. No abstract available.

3

Augmentation of T-cell response with a melanoma cell vaccine expressing specific HLA-A antigens.

Hoon DS, Morisaki T, Uchiyama A, Hayashi Y, Foshag LJ, Nizze AJ, Morton DL. Hoon DS, et al. Ann N Y Acad Sci. 1993 Aug 12;690:343-5. doi: 10.1111/j.1749-6632.1993.tb44025.x. Ann N Y Acad Sci. 1993. PMID: 8368751 No abstract available.

4

Plasma DNA microsatellites as tumor-specific markers and indicators of tumor progression in melanoma patients.

Fujiwara Y, Chi DD, Wang H, Keleman P, Morton DL, Turner R, Hoon DS. Fujiwara Y, et al. Among authors: hoon ds. Cancer Res. 1999 Apr 1;59(7):1567-71. Cancer Res. 1999. PMID: 10197630

5

Molecular markers in blood as surrogate prognostic indicators of melanoma recurrence.

Hoon DS, Bostick P, Kuo C, Okamoto T, Wang HJ, Elashoff R, Morton DL. Hoon DS, et al. Cancer Res. 2000 Apr 15;60(8):2253-7. Cancer Res. 2000. PMID: 10786692

6

Clinical significance of circulating DNA microsatellite markers in plasma of melanoma patients.

Nakayama T, Taback B, Nguyen DH, Chi DD, Morton DL, Fujiwara Y, Hoon DS. Nakayama T, et al. Among authors: hoon ds. Ann N Y Acad Sci. 2000 Apr;906:87-98. doi: 10.1111/j.1749-6632.2000.tb06596.x. Ann N Y Acad Sci. 2000. PMID: 10818602 No abstract available.

7

The clinical utility of multimarker RT-PCR in the detection of occult metastasis in patients with melanoma.

Taback B, Morton DL, O'Day SJ, Nguyen DH, Nakayama T, Hoon DS. Taback B, et al. Among authors: hoon ds. Recent Results Cancer Res. 2001;158:78-92. doi: 10.1007/978-3-642-59537-0_8. Recent Results Cancer Res. 2001. PMID: 11092035 Review.

8

Molecular staging of early colon cancer on the basis of sentinel node analysis: a multicenter phase II trial.

Bilchik AJ, Saha S, Wiese D, Stonecypher JA, Wood TF, Sostrin S, Turner RR, Wang HJ, Morton DL, Hoon DS. Bilchik AJ, et al. Among authors: hoon ds. J Clin Oncol. 2001 Feb 15;19(4):1128-36. doi: 10.1200/JCO.2001.19.4.1128. J Clin Oncol. 2001. PMID: 11181678 Clinical Trial.

9

Molecular clonality of in-transit melanoma metastasis.

Nakayama T, Taback B, Turner R, Morton DL, Hoon DS. Nakayama T, et al. Among authors: hoon ds. Am J Pathol. 2001 Apr;158(4):1371-8. doi: 10.1016/S0002-9440(10)64088-6. Am J Pathol. 2001. PMID: 11290555 Free PMC article.

10

Prognostic significance of circulating microsatellite markers in the plasma of melanoma patients.

Taback B, Fujiwara Y, Wang HJ, Foshag LJ, Morton DL, Hoon DS. Taback B, et al. Among authors: hoon ds. Cancer Res. 2001 Aug 1;61(15):5723-6. Cancer Res. 2001. PMID: 11479206

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

384 results

Search Page